- US-listed companies
- Ampio Pharmaceuticals, Inc.
- Income statement
Ampio Pharmaceuticals, Inc.【AMPE】Income statement
Market cap
$317.9K
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Revenue | - | - | - | - | 1 | - | - | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | 369,309 | - | - | - | - | - | - | - | - |
| Research & development | 9 | 17 | 35 | - | - | - | - | - | 13 | 9 | 12 | 9 | 2 |
| Selling, general & administrative | - | - | - | - | 15 | - | - | - | - | - | - | - | - |
| Operating margin (%) | - | - | - | - | - | - | - | - | - | - | - | - | |
| Operating expenses | 19 | 31 | 55 | 39 | 34 | 17 | 16 | 11 | 19 | 16 | 21 | 22 | 10 |
| Operating income | - | - | - | - | -33,302,119 | - | - | - | - | - | - | - | - |
| Income before tax | -18,276,734 | -11,593,045 | -24,528,426 | - | - | - | - | - | - | - | - | - | - |
| Net income | -18,359,234 | -11,593,045 | -24,008,558 | -38,125,415 | -32,010,242 | -19,163,629 | -51,891,945 | 34 | -13,630,000 | -15,894,000 | -17,075,000 | -16,337,000 | -8,632,000 |
| Net income margin (%) | - | - | - | - | - | - | - | - | - | - | - | - | |
| Earnings per share | - | - | - | - | - | - | - | - | -0.1 | -0.09 | -0.09 | -1.08 | -10.66 |
| Diluted EPS | - | - | - | - | - | - | - | - | -0.14 | -0.09 | -0.1 | -1.47 | -10.66 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | |
| EBITDA margin (%) | - | - | - | - | - | - | - | - | - | - | - | - |